• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing trends in vaccine efficacy by pathogen genetic distance.通过病原体遗传距离评估疫苗效力的趋势。
J Soc Fr Statistique (2009). 2020 Jul;161(1):164-175.
2
Estimating and Testing Vaccine Sieve Effects Using Machine Learning.使用机器学习估计和测试疫苗筛选效果
J Am Stat Assoc. 2019;114(527):1038-1049. doi: 10.1080/01621459.2018.1529594. Epub 2019 Apr 3.
3
Sieve analysis using the number of infecting pathogens.使用感染病原体数量进行筛分分析。
Biometrics. 2018 Sep;74(3):1023-1033. doi: 10.1111/biom.12833. Epub 2017 Dec 14.
4
Causal inference methods for vaccine sieve analysis with effect modification.疫苗筛选分析中具有效应修饰的因果推断方法。
Stat Med. 2022 Apr 15;41(8):1513-1524. doi: 10.1002/sim.9302. Epub 2022 Jan 19.
5
Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02 vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants.基于表位的筛检分析来自 FMP2.1/AS02 疫苗试验的恶性疟原虫序列与针对免疫相关 AMA1 变体的疫苗效力差异一致。
Vaccine. 2020 Jul 31;38(35):5700-5706. doi: 10.1016/j.vaccine.2020.06.035. Epub 2020 Jun 20.
6
Sieve analysis: methods for assessing from vaccine trial data how vaccine efficacy varies with genotypic and phenotypic pathogen variation.筛析:从疫苗试验数据评估疫苗效力如何随基因型和表型病原体变异而变化的方法。
J Clin Epidemiol. 2001 Jan;54(1):68-85. doi: 10.1016/s0895-4356(00)00258-4.
7
A unified evaluation of differential vaccine efficacy.统一评估疫苗效力差异。
Biometrics. 2020 Dec;76(4):1053-1063. doi: 10.1111/biom.13211. Epub 2020 Jan 6.
8
Comparison of competing risks failure time methods and time-independent methods for assessing strain variations in vaccine protection.比较用于评估疫苗保护中应变变异的竞争风险失败时间方法和与时间无关的方法。
Stat Med. 2000 Nov 30;19(22):3065-86. doi: 10.1002/1097-0258(20001130)19:22<3065::aid-sim600>3.0.co;2-d.
9
Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics.仅病例法在病因特异性危险模型中的应用:基于病毒和宿主遗传学评估疫苗效力差异。
Biostatistics. 2014 Jan;15(1):196-203. doi: 10.1093/biostatistics/kxt018. Epub 2013 Jun 27.
10
Testing and estimation of time-varying cause-specific hazard ratios with covariate adjustment.具有协变量调整的时变特定病因风险比的检验与估计。
Biometrics. 2008 Dec;64(4):1070-9. doi: 10.1111/j.1541-0420.2008.01012.x. Epub 2008 Mar 19.

引用本文的文献

1
Causal inference methods for vaccine sieve analysis with effect modification.疫苗筛选分析中具有效应修饰的因果推断方法。
Stat Med. 2022 Apr 15;41(8):1513-1524. doi: 10.1002/sim.9302. Epub 2022 Jan 19.
2
Test it earlier, result it faster, makes us stronger: how rapid viral diagnostics enable therapeutic success.检测得更早,结果更快,让我们更强:快速病毒诊断如何实现治疗成功。
Curr Opin Virol. 2021 Aug;49:111-116. doi: 10.1016/j.coviro.2021.05.007. Epub 2021 Jun 8.

本文引用的文献

1
Improved estimation of the cumulative incidence of rare outcomes.罕见结局累积发病率的估计得到改善。
Stat Med. 2018 Jan 30;37(2):280-293. doi: 10.1002/sim.7337. Epub 2017 Jul 2.
2
Statistical Inference for Data Adaptive Target Parameters.数据自适应目标参数的统计推断
Int J Biostat. 2016 May 1;12(1):3-19. doi: 10.1515/ijb-2015-0013.
3
Mark-specific hazard ratio model with missing multivariate marks.具有缺失多变量标记的特定标记风险比模型。
Lifetime Data Anal. 2016 Oct;22(4):606-25. doi: 10.1007/s10985-015-9353-9. Epub 2015 Oct 28.
4
Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.RTS,S/AS01疟疾疫苗的遗传多样性与保护效力
N Engl J Med. 2015 Nov 19;373(21):2025-2037. doi: 10.1056/NEJMoa1505819. Epub 2015 Oct 21.
5
Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy.具有多变量连续标记的标记特异性风险比模型:在疫苗效力中的应用
Biometrics. 2013 Jun;69(2):328-37. doi: 10.1111/biom.12016. Epub 2013 Feb 19.
6
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.RTS,S/AS01 疟疾疫苗在非洲婴儿中的 3 期临床试验。
N Engl J Med. 2012 Dec 13;367(24):2284-95. doi: 10.1056/NEJMoa1208394. Epub 2012 Nov 9.
7
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.增加 HIV-1 疫苗对具有 Env V2 遗传特征的病毒的功效。
Nature. 2012 Oct 18;490(7420):417-20. doi: 10.1038/nature11519. Epub 2012 Sep 10.
8
Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.带有多元连续标记的标记特异性比例风险模型及其在 HIV 疫苗功效试验中的应用。
Biostatistics. 2013 Jan;14(1):60-74. doi: 10.1093/biostatistics/kxs022. Epub 2012 Jul 3.
9
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.RTS,S/AS01 疟疾疫苗在非洲儿童中进行的 3 期临床试验的初步结果。
N Engl J Med. 2011 Nov 17;365(20):1863-75. doi: 10.1056/NEJMoa1102287. Epub 2011 Oct 18.
10
Targeted maximum likelihood estimation of effect modification parameters in survival analysis.生存分析中效应修饰参数的靶向最大似然估计。
Int J Biostat. 2011 Mar 30;7(1):19. doi: 10.2202/1557-4679.1307.

通过病原体遗传距离评估疫苗效力的趋势。

Assessing trends in vaccine efficacy by pathogen genetic distance.

作者信息

Benkeser David, Juraska Michal, Gilbert Peter B

机构信息

Department of Biostatistics and Bioinformatics, Emory University; 1518 Clifton Rd. NE; Atlanta, GA USA 30322.

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center; 1100 Fairview Ave. N; Seattle, WA USA 98109.

出版信息

J Soc Fr Statistique (2009). 2020 Jul;161(1):164-175.

PMID:33244440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7685316/
Abstract

Preventive vaccines are an effective public health intervention for reducing the burden of infectious diseases, but have yet to be developed for several major infectious diseases. Vaccine sieve analysis studies whether and how the efficacy of a vaccine varies with the genetics of the infectious pathogen, which may help guide future vaccine development and deployment. A standard statistical approach to sieve analysis compares the effect of the vaccine to prevent infection and disease caused by pathogen types defined dichotomously as genetically near or far from a reference pathogen strain inside the vaccine construct. For example, near may be defined by amino acid identity at all amino acid positions considered in a multiple alignment and far defined by at least one amino acid difference. An alternative approach is to study the efficacy of the vaccine as a function of genetic distance from a pathogen to a reference vaccine strain where the distance cumulates over the set of amino acid positions. We propose a nonparametric method for estimating and testing the trend in the effect of a vaccine across genetic distance. We illustrate the operating characteristics of the estimator via simulation and apply the method to a recent preventive malaria vaccine efficacy trial.

摘要

预防性疫苗是减轻传染病负担的一种有效公共卫生干预措施,但针对几种主要传染病的疫苗尚未研发出来。疫苗筛选分析研究疫苗效力是否以及如何随传染性病原体的基因变化,这可能有助于指导未来疫苗的研发和应用。一种用于筛选分析的标准统计方法是比较疫苗对预防由病原体类型引起的感染和疾病的效果,这些病原体类型被二分定义为在疫苗构建体中与参考病原体菌株在基因上接近或远离。例如,接近可以通过多重比对中考虑的所有氨基酸位置的氨基酸同一性来定义,而远则由至少一个氨基酸差异来定义。另一种方法是研究疫苗效力作为从病原体到参考疫苗菌株的遗传距离的函数,其中距离在氨基酸位置集合上累积。我们提出一种非参数方法来估计和检验疫苗效果在遗传距离上的趋势。我们通过模拟说明了估计器的操作特征,并将该方法应用于最近的预防性疟疾疫苗效力试验。